Literature DB >> 29087400

Colorectal Cancer Screening in the Non-Syndromic Familial Risk Population: Is It Time to Revise the Clinical Guidelines?

Enrique Quintero1,2,3, Antonio Z Gimeno-García1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29087400     DOI： 10.1038/ajg.2017.403

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  20 in total

Review 1.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

Authors:  Stuart R Cairns; John H Scholefield; Robert J Steele; Malcolm G Dunlop; Huw J W Thomas; Gareth D Evans; Jayne A Eaden; Matthew D Rutter; Wendy P Atkin; Brian P Saunders; Anneke Lucassen; Paul Jenkins; Peter D Fairclough; Christopher R J Woodhouse
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

2.  ASGE guideline: colorectal cancer screening and surveillance.

Authors:  Raquel E Davila; Elizabeth Rajan; Todd H Baron; Douglas G Adler; James V Egan; Douglas O Faigel; Seng-Ian Gan; William K Hirota; Jonathan A Leighton; David Lichtenstein; Waqar A Qureshi; Bo Shen; Marc J Zuckerman; Trina VanGuilder; Robert D Fanelli
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

3.  Effectiveness of a colonoscopic screening programme in first-degree relatives of patients with colorectal cancer.

Authors:  J J Puente Gutiérrez; M A Marín Moreno; J L Domínguez Jiménez; E Bernal Blanco; J M Díaz Iglesias
Journal:  Colorectal Dis       Date:  2011-06       Impact factor: 3.788

4.  Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis.

Authors:  Anastasia Katsoula; Paschalis Paschos; Anna-Bettina Haidich; Apostolos Tsapas; Olga Giouleme
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873

5.  Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.

Authors:  N Dekker; L G M van Rossum; M Van Vugt-van Pinxteren; S H C van Stiphout; R P M G Hermens; W A G van Zelst-Stams; M G H van Oijen; R J F Laheij; J B M J Jansen; N Hoogerbrugge
Journal:  Eur J Cancer       Date:  2011-02-28       Impact factor: 9.162

6.  Uptake of Colon Capsule Endoscopy vs Colonoscopy for Screening Relatives of Patients With Colorectal Cancer.

Authors:  Zaida Adrián-de-Ganzo; Onofre Alarcón-Fernández; Laura Ramos; Antonio Gimeno-García; Inmaculada Alonso-Abreu; Marta Carrillo; Enrique Quintero
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-29       Impact factor: 11.382

7.  Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.

Authors:  L M Hunt; P S Rooney; K Bostock; M H Robinson; J D Hardcastle; N C Armitage
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

8.  Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer.

Authors:  Robert E Schoen; Anthony Razzak; Kelly J Yu; Sonja I Berndt; Kevin Firl; Thomas L Riley; Paul F Pinsky
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.

Authors:  O Otero-Estévez; L De Chiara; F J Rodríguez-Berrocal; M Páez de la Cadena; J Cubiella; I Castro; C Gonzalez-Mao; V Hernandez; V S Martínez-Zorzano
Journal:  Br J Cancer       Date:  2014-12-02       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.